Ivy Natal
Latest round
- Seed
Last raised
- Apr 2020
Total raised
- Undisclosed
Investors
- 2
About Ivy Natal
Founded in 2020 in San Francisco, US, Ivy Natal specializes in innovative fertility technologies. The company was co-founded by Colin Bortner and Jeffrey Hsu, who both hold the CEO position.Ivy Natal specializes in next-generation fertility solutions by utilizing its proprietary cellular engineering platform to convert normal cells into reproductive cells. This innovative approach aims to address infertility challenges while also contributing to advancements in animal agriculture. The company's core product offerings include engineered reproductive cells designed for both human fertility treatments and agricultural applications, targeting a broad spectrum of end users, including fertility clinics, healthcare providers, and agricultural businesses. Ivy Natal’s products are designed to enhance the efficiency and success rates of reproductive procedures, ultimately catering to individuals facing infertility and agricultural entities seeking to improve livestock reproduction rates.Ivy Natal generates revenue through a combination of direct partnerships with fertility clinics and agricultural organizations, as well as potential licensing agreements for its advanced cellular technologies. The business model primarily focuses on B2B transactions, where the company collaborates with healthcare providers and agricultural firms to integrate its engineered reproductive cells into their existing systems. This collaborative framework allows for tailored solutions to specific challenges in fertility and agriculture, with transactions structured around project-based contracts and ongoing service agreements. Pricing plans for Ivy Natal’s offerings are determined based on the specific needs and scales of their clients, reflecting the customizable nature of their products and services.Ivy Natal is focused on expanding its product line and market presence. It is working on designing new engineered reproductive solutions targeted for release in 2023. The company plans to expand its geographical reach into additional regions across Europe and Asia by the end of 2024.
Who invested in Ivy Natal
2 investors across 1 round
See all investors in Ivy Natal
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Apr 14, 2020
Amount
Undisclosed
Investors
Questions about Ivy Natal
Who invested in Ivy Natal?
Ivy Natal has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Ivy Natal raised?
Ivy Natal has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Ivy Natal last raise money?
Ivy Natal's most recent round on record is a Seed, in Apr 2020.
What does Ivy Natal do?
Founded in 2020 in San Francisco, US, Ivy Natal specializes in innovative fertility technologies.
Where is Ivy Natal headquartered?
Ivy Natal is headquartered in San Francisco, US.
Which VCs invest in companies like Ivy Natal?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Ivy Natal's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Ivy Natal? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.